RMD Resmed Inc

Price (delayed)

$178.85

Market cap

$26.31B

P/E Ratio

29.51

Dividend/share

$1.88

EPS

$6.06

Enterprise value

$27.49B

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
The price to earnings (P/E) is 36% lower than the 5-year quarterly average of 46.2 and 6% lower than the last 4 quarters average of 31.3
Resmed's debt has decreased by 28% YoY and by 7% QoQ
Resmed's quick ratio has increased by 5% from the previous quarter but it has decreased by 2.4% YoY
Resmed's gross margin has decreased by 2.8% YoY

Key stats

What are the main financial stats of RMD
Market
Shares outstanding
147.09M
Market cap
$26.31B
Enterprise value
$27.49B
Valuations
Price to book (P/B)
5.87
Price to sales (P/S)
5.84
EV/EBIT
23.77
EV/EBITDA
20.05
EV/Sales
6.1
Earnings
Revenue
$4.5B
EBIT
$1.16B
EBITDA
$1.37B
Free cash flow
$962.46M
Per share
EPS
$6.06
Free cash flow per share
$6.54
Book value per share
$30.47
Revenue per share
$30.61
TBVPS
$23.89
Balance sheet
Total assets
$6.91B
Total liabilities
$2.42B
Debt
$1.39B
Equity
$4.48B
Working capital
$1.61B
Liquidity
Debt to equity
0.31
Current ratio
3.11
Quick ratio
1.23
Net debt/EBITDA
0.86
Margins
EBITDA margin
30.4%
Gross margin
55.1%
Net margin
19.8%
Operating margin
25.3%
Efficiency
Return on assets
13.1%
Return on equity
21.2%
Return on invested capital
29%
Return on capital employed
18.8%
Return on sales
25.7%
Dividend
Dividend yield
1.05%
DPS
$1.88
Payout ratio
31%

RMD stock price

How has the Resmed stock price performed over time
Intraday
0.7%
1 week
-3.77%
1 month
-7.34%
1 year
-19.57%
YTD
3.97%
QTD
-9.69%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$4.5B
Gross profit
$2.48B
Operating income
$1.14B
Net income
$890.39M
Gross margin
55.1%
Net margin
19.8%
The company's revenue rose by 20% YoY and by 2.9% QoQ
The gross profit has grown by 16% YoY and by 2.8% from the previous quarter
RMD's net income is up by 10% YoY
RMD's operating income is up by 9% YoY

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
P/E
29.51
P/B
5.87
P/S
5.84
EV/EBIT
23.77
EV/EBITDA
20.05
EV/Sales
6.1
The price to earnings (P/E) is 36% lower than the 5-year quarterly average of 46.2 and 6% lower than the last 4 quarters average of 31.3
The EPS has increased by 10% YoY
RMD's P/B is 38% below its 5-year quarterly average of 9.5 and 12% below its last 4 quarters average of 6.7
RMD's equity is up by 20% year-on-year and by 5% since the previous quarter
The P/S is 31% lower than the 5-year quarterly average of 8.5 and 10% lower than the last 4 quarters average of 6.5
The company's revenue rose by 20% YoY and by 2.9% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital fell by 12% YoY
The ROA has decreased by 11% YoY and by 3% from the previous quarter
Resmed's ROE has decreased by 9% YoY and by 6% from the previous quarter
The ROS has decreased by 6% YoY and by 3.7% from the previous quarter

Dividends

What is RMD's dividend history
DPS
$1.88
Dividend yield
1.05%
Payout ratio
31%
Recent dividends

Financial health

How did Resmed financials performed over time
The company's total assets is 185% higher than its total liabilities
RMD's total liabilities is down by 18% year-on-year and by 2.7% since the previous quarter
Resmed's quick ratio has increased by 5% from the previous quarter but it has decreased by 2.4% YoY
Resmed's debt is 69% lower than its equity
Resmed's debt to equity has decreased by 40% YoY and by 11% QoQ
Resmed's debt has decreased by 28% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.